from: Boshoff et al (2004). The transcriptional responses of Mycobacterium tuberculosis to inhibitors of metabolism. J Biol Chem.

Gene Expression Profile for Rv2005c/-

LFCtreatmentdescriptionclass of inhibitor

-0.914

Amikacinug/mL Amikacintranslation

-0.914

Cap5-10ug/mL Capreomycintranslation

-1.208

Rox10-50 ug/mL Roxithromycintranslation

-0.691

SM2-5 ug/mL Streptomycintranslation

-1.611

Tet5-10 ug/mL Tetracyclinetranslation

-0.033

Rif0.2-5ug/mL Rifampicintranscription

-0.471

Rifp0.1-0.5ug/mL Rifapentinetranscription

1.427

Min_med__succinate_Minimal medium with succinate as sole carbon source as compared to growth in 7H9/ADC/Tween/glycerolstarvation

1.944

CCCP10-50 uM Carbonyl cyanide 3-chlorophenylhydrazonerespiration

0.597

CPZ10-50 ug/mL Chlorpromazinerespiration

0.555

Clofazimine10-13 ug/mL Clofaziminerespiration

0.033

Clotrimazole10-24 ug/mL Clotrimazole (azole drug)respiration

3.301

DCCD20-100 uM Dicyclohexylcarbodiimiderespiration

2.250

DNP"0.5-2.5 mM 2,4-Dinitrophenol"respiration

0.590

DTT"1-2 mM 1,4-Dithio-DL-threitol"respiration

0.130

Econazole10-24 ug/mL Econazole (azole drug)respiration

0.138

GSNO_CFZ0.1 mM S-Nitrosoglutathione + 5 ug/mL Clofaziminerespiration

1.103

GSNO_CPZ0.1 mM S-Nitrosoglutathione + 20-25 ug/mL Chlorpromazinerespiration

0.433

GSNO_KCN0.1mM S-Nitrosoglutathione + 5ug/mL potassium cyaniderespiration

0.419

GSNO_menadione0.1 mM S-Nitrosoglutathione + 6-10 ug/mL menadionerespiration

1.820

KCN5-20 ug/mL Potassium cyaniderespiration

0.047

NaN30.2-2 mM Sodium aziderespiration

0.079

Nigericin50 uM Nigericinrespiration

0.956

TRC10-150 ug/mL Triclosanrespiration

1.296

TRZ10-25 ug/mL Thioridazinerespiration

1.193

Valinomycin0.5-10 uM Valinomycinrespiration

-0.382

ZnSO42 mM ZnSO4respiration

-0.171

menadione6-10 ug/mL Menadionerespiration

-0.208

Ascididemin_Nat_prod4-9 ug/mL Organic extract of Eudistoma amplumironLimitation

-0.524

Deferoxamine150-250 uM Deferoxamine mesylateironLimitation

-0.659

Dipyridyl"100-200 uM 2,2'-Bipyridyl"ironLimitation

0.674

GSNO0.02-0.1mM S-NitrosoglutathionedosRassociated

2.707

NRP_1Non-replicating persistence stage 1dosRassociated

-0.467

Amp0.2mg/mL AmpicillincellWall

-0.467

Cephalexin20-100 ug/mL CephalexincellWall

-0.611

Cerulenin0.32-5 ug/mL CerulenincellWall

-0.411

DIPED5-100 ug/mL DiisopropylethylenediaminecellWall

-0.202

EMB10-20 ug/mL EthambutolcellWall

-0.392

Eta12-40 ug/mL EthionamidecellWall

-0.390

INH0.2-0.4 ug/mL IsoniazidcellWall

-0.338

TLM0.1-0.2 mg/mL ThiolactomycincellWall

0.083

PalmitateMinimal medium with palmitate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

-0.598

SuccinateMinimal medium with succinate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

-0.648

BZA0.12 mg/mL BenzamidearomaticAmides

-0.864

Nam0.12 - 1.2 mg/mL NicotinamidearomaticAmides

-0.870

PZA0.12-1.2 mg/mL PyrazinamidearomaticAmides

-0.503

H2O24 mM hydrogen peroxideDNAdamaging

-0.476

Levo10 ug/mL LevofloxacinDNAdamaging

-0.815

Mtm0.1-0.2 ug/mL Mitomycin CDNAdamaging

0.187

Novobiocin10 ug/mL NovobiocinDNAdamaging

-0.461

Oflox5-10 ug/mL OfloxacinDNAdamaging

-0.334

UVUV-irradiationDNAdamaging

3.717

ARP41-4 ug/mL Antitubercular compound ARP4?

-0.190

Antimycin12.5-50 ug/mL Antimycin A?

-0.306

DTNB"1-2 mM 5,5'-Dithiobis(2-nitrobenzoic acid)"?

-0.226

PA_110-50 ug/mL Antitubercular compound PA-1?

-0.094

PA_2110-50 ug/mL Antitubercular compound PA-21?

0.843

PA8240.2-2 ug/mL PA-824?

2.042

Procept_677620-30 ug/mL Antitubercular compound Procept 6776?

0.279

Procept_67785-40 ug/mL Antitubercular compound Procept 6778?

-0.207

Verapamil50 uM Verapamil?

-0.119

mercaptoethanol2 mM 2-Mercaptoethanol?

-0.340

methoxatin10-20 ug/mL Methoxatin?